Inactive Instrument

MYM Nutraceuticals Inc.

Equities

MYM

CA55406A1012

MYM Nutraceuticals Inc. Announces Resignation of Ian Ramage as Director and General Counsel

October 06, 2018 at 02:00 am IST

MYM Nutraceuticals Inc. announced that the board of directors received the resignation of Ian Ramage as Director and General Counsel. He resigns from the board to focus his efforts on other professional opportunities.

Latest news about MYM Nutraceuticals Inc.

IM Cannabis : Dual-Listed IM Cannabis Closes Acquisition of MYM Nutraceuticals	09/21/09	MT
IM Cannabis Corp. completed the acquisition of MYM Nutraceuticals Inc. from group of shareholders.	09/21/09	CI
MYM Nutraceuticals Inc. Reports Earnings Results for the Third Quarter Ended February 28, 2021	30/21/30	CI
IM Cannabis : Agrees to Purchase MYM Nutraceuticals, its Licensed Producer Subsidiary Highland Grow	01/21/01	MT
IM Cannabis Corp. entered into a definitive agreement to acquire MYM Nutraceuticals Inc. from group of shareholders for CAD 71.9 million.	01/21/01	CI
Highland Grow Expands Distribution into Nunavut	08/21/08	CI
Mym Nutraceuticals Inc. Reports Earnings Results for the Second Quarter Ended November 30, 2020	29/21/29	CI
MYM Nutraceuticals Inc. Launches Coastal Connection Brand in Nova Scotia Market	03/20/03	CI
Mym Nutraceuticals Inc. Reports Earnings Results for the First Quarter Ended August 31, 2020	30/20/30	CI
Mym Nutraceuticals Inc. Reports Earnings Results for the Full Year Ended May 31, 2020	28/20/28	CI
MYM Nutraceuticals Inc. completed the acquisition of Highland Grow Inc. from Biome Grow Inc..	31/20/31	CI
MYM Nutraceuticals Inc. Enter into A Loan Facility with 1909203 Ontario Inc	27/20/27	CI
MYM Nutraceuticals Inc. Announces Management Changes	27/20/27	CI
MYM Nutraceuticals Inc. Appoints Michael Wiener as Chief Executive Officer	27/20/27	CI
MYM Nutraceuticals Inc. entered into an agreement to acquire Highland Grow Inc. from Biome Grow Inc. for CAD 12.9 million.	27/20/27	CI
MYM Nutraceuticals Inc. announced that it has received CAD 0.075 million in funding	09/20/09	CI
MYM Nutraceuticals Inc. acquired the remaining 7% stake in CannaCanada Inc.	09/20/09	CI
MYM Nutraceuticals Inc. acquired remaining 25% stake in Sublime Culture Inc. for CAD 0.61 million.	02/20/02	CI
MYM Nutraceuticals Inc. announced that it has received CAD 0.075 million in funding	05/20/05	CI
MYM Nutraceuticals Inc. announced that it has received CAD 1.266295 million in funding	25/20/25	CI
Mym Nutraceuticals Inc. Reports Earnings Results for the Third Quarter Ended February 29, 2020	21/20/21	CI
MYM Nutraceuticals Inc. Announces Executive Changes	04/20/04	CI
MYM Nutraceuticals Inc. announced a financing transaction	14/20/14	CI
Mym Nutraceuticals Inc. Reports Earnings Results for the Second Quarter Ended November 30, 2019	10/20/10	CI
MYM Nutraceuticals Inc. Announces Executive Changes	03/20/03	CI

Chart MYM Nutraceuticals Inc.

Duration

Period

More charts

Company Profile

Mym Nutraceuticals Inc, formerly My Marijuana Canada Inc, is a Canada-based company, which is focused on producing cannabis. The Company is engaged in building three scale production facilities in both Canada and Australia. The Company has the following projects: The Weedon Project, which includes a cannabis museum and a cannabis university for industry training and located in Quebec, Canada; The Laval Project is based on the manufacturing Tetrahydrocannabinol and Cannabidiol (CBD) products across Canada and the United States; The Northern Rivers Project is engaged in the production of cannabis in New South Wales, Australia, as well as MJT Manufacturing Project, its production facility located in Toronto, is focused on the production of CBD extracts and isolates. The MJT production facility is focused on product development for the Company's owned brands. Its portfolio brands include such CBD brands as HempMed, Joshua Tree and Dr.Furbaby. Its products are being sold in Canada.

Sector

More about the company